Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 46:1705-1709, doi:10.1016/j.jacc.2005.05.090 (Published online 7 October 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (97)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tantry, U. S.
Right arrow Articles by Gurbel, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tantry, U. S.
Right arrow Articles by Gurbel, P. A.

Overestimation of Platelet Aspirin Resistance Detection by Thrombelastograph Platelet Mapping and Validation by Conventional Aggregometry Using Arachidonic Acid Stimulation

Udaya S. Tantry, PhD, Kevin P. Bliden, BS and Paul A. Gurbel, MD, FACC*

Sinai Center for Thrombosis Research, Baltimore, Maryland



View larger version (12K):

[in a new window]
 
Figure 1 Scatter plot showing 1 mmol/l arachidonic acid-induced platelet aggregation by light-transmittance aggregometry in individual healthy subjects (n = 6) (before and after aspirin therapy), compliant (n = 196) and non-compliant patients (n = 7) undergoing percutaneous interventions (PCIs) (before and after PCI), and patients with a history of stent thrombosis (SAT).

 


View larger version (13K):

[in a new window]
 
Figure 2 Scatter plot showing 1 mmol/l arachidonic acid-induced platelet aggregation by thrombelastography in individual healthy subjects (n = 6) (before and after aspirin therapy), compliant (n = 196) and non-compliant patients (n = 7) undergoing percutaneous interventions (PCIs) (before and after PCI), and patients with a history of stent thrombosis (SAT).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement